The Journal of General Physiology
Cell MicroControls
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article
Right arrow Full Text
Right arrow PDF (Full Text)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JGP
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Giangiacomo, K. M.
Right arrow Articles by McManus, O. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Giangiacomo, K. M.
Right arrow Articles by McManus, O. B.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J. Gen. Physiol., Volume 112, Number 4, October 1, 1998 485-501

Mechanism of Maxi-K Channel Activation by Dehydrosoyasaponin-I

Kathleen M. Giangiacomo,* Augustus Kamassah,Dagger Guy Harris,§ and Owen B. McManusDagger

From the * Department of Biochemistry, Temple University School of Medicine, Philadelphia, Pennsylvania 19140; and Dagger   Department of Membrane Biochemistry and Biophysics, and §  Department of Natural Products Chemistry, Merck Research Labs, Rahway, New Jersey 07065

Dehydrosoyasaponin-I (DHS-I) is a potent activator of high-conductance, calcium-activated potassium (maxi-K) channels. Interaction of DHS-I with maxi-K channels from bovine aortic smooth muscle was studied after incorporating single channels into planar lipid bilayers. Nanomolar amounts of intracellular DHS-I caused the appearance of discrete episodes of high channel open probability interrupted by periods of apparently normal activity. Statistical analysis of these periods revealed two clearly separable gating modes that likely reflect binding and unbinding of DHS-I. Kinetic analysis of durations of DHS-I-modified modes suggested DHS-I activates maxi-K channels through a high-order reaction. Average durations of DHS-I-modified modes increased with DHS-I concentration, and distributions of these mode durations contained two or more exponential components. In addition, dose-dependent increases in channel open probability from low initial values were high order with average Hill slopes of 2.4-2.9 under different conditions, suggesting at least three to four DHS-I molecules bind to maximally activate the channel. Changes in membrane potential over a 60-mV range appeared to have little effect on DHS-I binding. DHS-I modified calcium- and voltage-dependent channel gating. 100 nM DHS-I caused a threefold decrease in concentration of calcium required to half maximally open channels. DHS-I shifted the midpoint voltage for channel opening to more hyperpolarized potentials with a maximum shift of -105 mV. 100 nM DHS-I had a larger effect on voltage-dependent compared with calcium-dependent channel gating, suggesting DHS-I may differentiate these gating mechanisms. A model specifying four identical, noninteracting binding sites, where DHS-I binds to open conformations with 10-20-fold higher affinity than to closed conformations, explained changes in voltage-dependent gating and DHS-I-induced modes. This model of channel activation by DHS-I may provide a framework for understanding protein structures underlying maxi-K channel gating, and may provide a basis for understanding ligand activation of other ion channels.

Key words: calcium-activated potassium channelpotassium channel agonistion channel gatingion channel pharmacology


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Biophys. JHome page
T. Lu, D. Ye, T. He, X.-l. Wang, H.-l. Wang, and H.-C. Lee
Impaired Ca2+-Dependent Activation of Large-Conductance Ca2+-Activated K+ Channels in the Coronary Artery Smooth Muscle Cells of Zucker Diabetic Fatty Rats
Biophys. J., December 1, 2008; 95(11): 5165 - 5177.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
M. A. Seibold, B. Wang, C. Eng, G. Kumar, K. B. Beckman, S. Sen, S. Choudhry, K. Meade, M. Lenoir, H. G. Watson, et al.
An african-specific functional polymorphism in KCNMB1 shows sex-specific association with asthma severity
Hum. Mol. Genet., September 1, 2008; 17(17): 2681 - 2690.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
X.-H. Sun, J.-P. Ding, H. Li, N. Pan, L. Gan, X.-L. Yang, and H.-B. Xu
Activation of Large-Conductance Calcium-Activated Potassium Channels by Puerarin: The Underlying Mechanism of Puerarin-Mediated Vasodilation
J. Pharmacol. Exp. Ther., October 1, 2007; 323(1): 391 - 397.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. P. Torres, F. J. Morera, I. Carvacho, and R. Latorre
A Marriage of Convenience: beta-Subunits and Voltage-dependent K+ Channels
J. Biol. Chem., August 24, 2007; 282(34): 24485 - 24489.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. N. Bukiya, J. Liu, L. Toro, and A. M. Dopico
beta1 (KCNMB1) Subunits Mediate Lithocholate Activation of Large-Conductance Ca2+-Activated K+ Channels and Dilation in Small, Resistance-Size Arteries
Mol. Pharmacol., August 1, 2007; 72(2): 359 - 369.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
T. Morimoto, K. Sakamoto, H. Sade, S. Ohya, K. Muraki, and Y. Imaizumi
Voltage-Sensitive Oxonol Dyes Are Novel Large-Conductance Ca2+-Activated K+ Channel Activators Selective for beta1 and beta4 but Not for beta2 Subunits
Mol. Pharmacol., April 1, 2007; 71(4): 1075 - 1088.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
T. S. Ha, H.-H. Lim, G. E. Lee, Y.-C. Kim, and C.-S. Park
Electrophysiological Characterization of Benzofuroindole-Induced Potentiation of Large-Conductance Ca2+-Activated K+ Channels
Mol. Pharmacol., March 1, 2006; 69(3): 1007 - 1014.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
K. Sakamoto, T. Nonomura, S. Ohya, K. Muraki, T. Ohwada, and Y. Imaizumi
Molecular Mechanisms for Large Conductance Ca2+-Activated K+ Channel Activation by a Novel Opener, 12,14-Dichlorodehydroabietic Acid
J. Pharmacol. Exp. Ther., January 1, 2006; 316(1): 144 - 153.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
H. Sade, K. Muraki, S. Ohya, N. Hatano, and Y. Imaizumi
Activation of large-conductance, Ca2+-activated K+ channels by cannabinoids
Am J Physiol Cell Physiol, January 1, 2006; 290(1): C77 - C86.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
K. Nishimaru, M. Eghbali, R. Lu, J. Marijic, E. Stefani, and L. Toro
Functional and molecular evidence of MaxiK channel {beta}1 subunit decrease with coronary artery ageing in the rat
J. Physiol., September 15, 2004; 559(3): 849 - 862.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
X. Qian, C. M. Nimigean, X. Niu, B. L. Moss, and K. L. Magleby
Slo1 Tail Domains, but Not the Ca2+ Bowl, Are Required for the {beta}1 Subunit to Increase the Apparent Ca2+ Sensitivity of BK Channels
J. Gen. Physiol., November 25, 2002; 120(6): 829 - 843.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
Y. Imaizumi, K. Sakamoto, A. Yamada, A. Hotta, S. Ohya, K. Muraki, M. Uchiyama, and T. Ohwada
Molecular Basis of Pimarane Compounds as Novel Activators of Large-Conductance Ca2+-Activated K+ Channel alpha -Subunit
Mol. Pharmacol., October 1, 2002; 62(4): 836 - 846.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
B. Nilius and G. Droogmans
Ion Channels and Their Functional Role in Vascular Endothelium
Physiol Rev, October 1, 2001; 81(4): 1415 - 1459.
[Abstract] [Full Text] [PDF]



  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents